Implementation of Pharmaceutical Care or Hypertension Patients in Communty Health Center of Lubuk Pakamdeli Serdang

Yosi Darmirani; Aminah  Dalimunthe; Khairunnisa Khairunnisa

doi:10.37899/journallamedihealtico.v5i3.1447

Yosi Darmirani Master of Pharmaceutical Sciences Study Program, Faculty of Pharmacy, University of North Sumatra
Aminah Dalimunthe Department of Pharmacology, Faculty of Pharmacy, University of North Sumatra
Khairunnisa Department of Pharmacology, Faculty of Pharmacy, University of North Sumatra

DOI: https://doi.org/10.37899/journallamedihealtico.v5i3.1447

Keywords: Pharmaceutical care, Hypertension, DRPs, Outcometherapy, Adherence, Quality of life

Abstract

The objective of this research was to provide pharmaceutical care to patients with Hypertension and assess its effects on the occurrence of drug-related problems (DRPs), clinical outcomes, adherence levels, and quality of life of Hypertension patients at Puskesmas (Community Health Center) Lubuk Pakam. This research used a comparative experimental approach using a prospective cohort study design to assess the effects of an intervention on 73 individuals with Hypertension between March and August 2021. The PCNE V9.00 instrument was used to identify the occurrence of Drug-Related Problems (DRPs). Adherence level data was collected through the MMAS-8 questionnaire. Random blood glucose (RBG) data and Blood Pressure values were obtained by directly examining patients. The EQ-5D-3L questionnaire was used to gather data on the quality of life. The data were analyzed using the Wilcoxon Signed-Rank test and Friedman test in the SPSS V22.0 software. The findings indicated that the average occurrence of drug-related problems (DRPs) before to the intervention was 1.436 ± 0.502, however after the intervention, it decreased to 0.282 ± 0.456 (α <0.05). The mean blood pressure before to the intervention was 278.58 ± 75.278 mmHg, whereas after the intervention it decreased to 179.68 ± 14.008 mmHg (α <0.05). There was a substantial rise in the mean adherence score before to the intervention, from 5.00 ± 0.89 to 8.48 ± 0.77 (α<0.05). Similarly, the average quality of life score increased from 0.878 ± 0.176 to 1 ± 0.09 after the intervention (α<0.05).

References

Ahmad, A., & Oparil, S. (2017). Hypertension in women: recent advances and lingering questions. Hypertension, 70(1), 19-26.

Ahn, S., Romo, R. D., & Campbell, C. L. (2020). A systematic review of interventions for family caregivers who care for patients with advanced cancer at home. Patient education and counseling, 103(8), 1518-1530. https://doi.org/10.1016/j.pec.2020.03.012

Arikunto, S. (2013). Contribution of Educational Management to Optimal Service of Educational Development. Jumal Bimbingan dan Konseling “PSIKOPEDAGOGIA, 2(2), 70-77.

Aziz, F., Malek, S., Ali, A. M., Wong, M. S., Mosleh, M., & Milow, P. (2020). Determining hypertensive patients’ beliefs towards medication and associations with medication adherence using machine learning methods. PeerJ, 8, e8286. https://doi.org/10.7717/peerj.8286

Corrao, G., Parodi, A., Zambon, A., Heiman, F., Filippi, A., Cricelli, C., ... & Mancia, G. (2010). Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. Journal of hypertension, 28(7), 1584-1590. https://doi.org/10.1097/HJH.0b013e328339f9fa

Dosh, S.A. (2001). The Diagnosis of Essential and Secondary Hypertension in Adults.J.Fam Pract. 50(1): 707-712.

Liau, S. J., Lalic, S., Sluggett, J. K., Cesari, M., Onder, G., Vetrano, D. L., ... & Bell, J. S. (2021). Medication management in frail older people: consensus principles for clinical practice, research, and education. Journal of the American Medical Directors Association, 22(1), 43-49. https://doi.org/10.1016/j.jamda.2020.05.004

Martini, F., Fregna, L., Bosia, M., Perrozzi, G., & Cavallaro, R. (2022). Substance-related disorders. In Fundamentals of Psychiatry for Health Care Professionals (pp. 263-295). Cham: Springer International Publishing.

Rikmasari, Y., Kristina, S. A., Andayani, T. M., & Endarti, D. (2021). An Economic Evaluation of Pharmacist'Intervention to Improve Blood Pressure Control: A Systematic Review. International Journal of Pharmaceutical Research (09752366), 13(2).

Riskesdas (2007).Riset Kesehatan Dasar. Jakarta:Departemen Kesehatan RI. Hal.110-112.

Setyoningsih, H., & Zaini, F. (2022). Hubungan Interaksi Obat Terhadap Efektivitas Obat Antihipertensi di RSUD dr. R. Soetrasno Rembang. Cendekia Journal of Pharmacy, 6(1), 76-88.

Tesfaye, W. H., Erku, D., Mekonnen, A., Tefera, Y. G., Castelino, R., Sud, K., ... & Obamiro, K. (2021). Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change wheel. Journal of nephrology, 1-35. https://doi.org/10.1007/s40620-020-00895-x

WHO. (2001).Pengendalian Hipertensi. Alih Bahasa: Prof. Dr. Kosasih Padmawinata. Bandung: Penerbit ITB.Hal. 14, 50-51.

WHO. (2013). Department of Psychiatry Centre for Participant Report Outcomes. Diakses 02 Desember 2020.